AtriCure, Inc. (ATRC) Reports Q4 Loss of $0.13
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.80 +6.19%
Revenue Growth %: +11.7%
Financial Fact:
Other: -32K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +11.7%
Financial Fact:
Other: -32K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Pfizer reafffirms 2026 guidance after CFO transition announcement
- UBS Reiterates Buy Rating on Hasbro (HAS) on FY Upside Potential Despite Unchanged Guide
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
